The global market for Endocrine Therapy Drugs (ETDs) was estimated to be worth US$ 812 million in 2023 and is forecast to a readjusted size of US$ 1198.9 million by 2030 with a CAGR of 5.9% during the forecast period 2024-2030

Endocrine Therapy Drugs (ETDs) - Market

Endocrine Therapy Drugs (ETDs) play a pivotal role in treating hormone receptor-positive cancers, such as breast and prostate cancer. These drugs function by disrupting the hormonal signaling pathways that fuel tumor growth, effectively inhibiting cancer cell proliferation. By targeting specific hormones or their receptors, ETDs offer a targeted and less toxic approach compared to traditional chemotherapy. They have revolutionized cancer management, improving survival rates, and enhancing the quality of life for patients. Ongoing research continues to refine existing ETDs and develop new ones, promising even greater efficacy and personalized treatment options for individuals battling hormone-driven cancers.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Endocrine Therapy Drugs (ETDs), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Endocrine Therapy Drugs (ETDs) by region & country, by Type, and by Application.

The Endocrine Therapy Drugs (ETDs) market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrine Therapy Drugs (ETDs).

Market Segmentation

Scope of Endocrine Therapy Drugs (ETDs) - Market Report

Report Metric	Details
Report Name	Endocrine Therapy Drugs (ETDs) - Market
Forecasted market size in 2030	US$ 1198.9 million
CAGR	5.9%
Forecasted years	2024 - 2030
Segment by Type:	Antidiabetic Drugs Anti-osteoporosis Drugs Contraceptive Other
Segment by Application	Diabetes Treatment Osteoporosis Treatment Contraception Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novo Nordisk, AstraZeneca, Generex Biotechnology, Sanofi, MSD, Pfizer, Huadong Medicine, Bayer, Tonghua Dongbao Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Endocrine Therapy Drugs (ETDs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Endocrine Therapy Drugs (ETDs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Endocrine Therapy Drugs (ETDs) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Endocrine Therapy Drugs (ETDs) - Market size in 2030?

Ans: The Endocrine Therapy Drugs (ETDs) - Market size in 2030 will be US$ 1198.9 million.

Who are the main players in the Endocrine Therapy Drugs (ETDs) - Market report?

Ans: The main players in the Endocrine Therapy Drugs (ETDs) - Market are Novo Nordisk, AstraZeneca, Generex Biotechnology, Sanofi, MSD, Pfizer, Huadong Medicine, Bayer, Tonghua Dongbao Pharmaceutical

What are the Application segmentation covered in the Endocrine Therapy Drugs (ETDs) - Market report?

Ans: The Applications covered in the Endocrine Therapy Drugs (ETDs) - Market report are Diabetes Treatment, Osteoporosis Treatment, Contraception, Other

What are the Type segmentation covered in the Endocrine Therapy Drugs (ETDs) - Market report?

Ans: The Types covered in the Endocrine Therapy Drugs (ETDs) - Market report are Antidiabetic Drugs, Anti-osteoporosis Drugs, Contraceptive, Other

1 Market Overview

1.1 Endocrine Therapy Drugs (ETDs) Product Introduction

1.2 Global Endocrine Therapy Drugs (ETDs) Market Size Forecast

1.2.1 Global Endocrine Therapy Drugs (ETDs) Sales Value (2019-2030)

1.2.2 Global Endocrine Therapy Drugs (ETDs) Sales Volume (2019-2030)

1.2.3 Global Endocrine Therapy Drugs (ETDs) Sales Price (2019-2030)

1.3 Endocrine Therapy Drugs (ETDs) Market Trends & Drivers

1.3.1 Endocrine Therapy Drugs (ETDs) Industry Trends

1.3.2 Endocrine Therapy Drugs (ETDs) Market Drivers & Opportunity

1.3.3 Endocrine Therapy Drugs (ETDs) Market Challenges

1.3.4 Endocrine Therapy Drugs (ETDs) Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Endocrine Therapy Drugs (ETDs) Players Revenue Ranking (2023)

2.2 Global Endocrine Therapy Drugs (ETDs) Revenue by Company (2019-2024)

2.3 Global Endocrine Therapy Drugs (ETDs) Players Sales Volume Ranking (2023)

2.4 Global Endocrine Therapy Drugs (ETDs) Sales Volume by Company Players (2019-2024)

2.5 Global Endocrine Therapy Drugs (ETDs) Average Price by Company (2019-2024)

2.6 Key Manufacturers Endocrine Therapy Drugs (ETDs) Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Endocrine Therapy Drugs (ETDs) Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Endocrine Therapy Drugs (ETDs)

2.9 Endocrine Therapy Drugs (ETDs) Market Competitive Analysis

2.9.1 Endocrine Therapy Drugs (ETDs) Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Endocrine Therapy Drugs (ETDs) Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Therapy Drugs (ETDs) as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Antidiabetic Drugs

3.1.2 Anti-osteoporosis Drugs

3.1.3 Contraceptive

3.1.4 Other

3.2 Global Endocrine Therapy Drugs (ETDs) Sales Value by Type

3.2.1 Global Endocrine Therapy Drugs (ETDs) Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Endocrine Therapy Drugs (ETDs) Sales Value, by Type (2019-2030)

3.2.3 Global Endocrine Therapy Drugs (ETDs) Sales Value, by Type (%) (2019-2030)

3.3 Global Endocrine Therapy Drugs (ETDs) Sales Volume by Type

3.3.1 Global Endocrine Therapy Drugs (ETDs) Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Endocrine Therapy Drugs (ETDs) Sales Volume, by Type (2019-2030)

3.3.3 Global Endocrine Therapy Drugs (ETDs) Sales Volume, by Type (%) (2019-2030)

3.4 Global Endocrine Therapy Drugs (ETDs) Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Diabetes Treatment

4.1.2 Osteoporosis Treatment

4.1.3 Contraception

4.1.4 Other

4.2 Global Endocrine Therapy Drugs (ETDs) Sales Value by Application

4.2.1 Global Endocrine Therapy Drugs (ETDs) Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Endocrine Therapy Drugs (ETDs) Sales Value, by Application (2019-2030)

4.2.3 Global Endocrine Therapy Drugs (ETDs) Sales Value, by Application (%) (2019-2030)

4.3 Global Endocrine Therapy Drugs (ETDs) Sales Volume by Application

4.3.1 Global Endocrine Therapy Drugs (ETDs) Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Endocrine Therapy Drugs (ETDs) Sales Volume, by Application (2019-2030)

4.3.3 Global Endocrine Therapy Drugs (ETDs) Sales Volume, by Application (%) (2019-2030)

4.4 Global Endocrine Therapy Drugs (ETDs) Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Endocrine Therapy Drugs (ETDs) Sales Value by Region

5.1.1 Global Endocrine Therapy Drugs (ETDs) Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Endocrine Therapy Drugs (ETDs) Sales Value by Region (2019-2024)

5.1.3 Global Endocrine Therapy Drugs (ETDs) Sales Value by Region (2025-2030)

5.1.4 Global Endocrine Therapy Drugs (ETDs) Sales Value by Region (%), (2019-2030)

5.2 Global Endocrine Therapy Drugs (ETDs) Sales Volume by Region

5.2.1 Global Endocrine Therapy Drugs (ETDs) Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Endocrine Therapy Drugs (ETDs) Sales Volume by Region (2019-2024)

5.2.3 Global Endocrine Therapy Drugs (ETDs) Sales Volume by Region (2025-2030)

5.2.4 Global Endocrine Therapy Drugs (ETDs) Sales Volume by Region (%), (2019-2030)

5.3 Global Endocrine Therapy Drugs (ETDs) Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Endocrine Therapy Drugs (ETDs) Sales Value, 2019-2030

5.4.2 North America Endocrine Therapy Drugs (ETDs) Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Endocrine Therapy Drugs (ETDs) Sales Value, 2019-2030

5.5.2 Europe Endocrine Therapy Drugs (ETDs) Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Endocrine Therapy Drugs (ETDs) Sales Value, 2019-2030

5.6.2 Asia Pacific Endocrine Therapy Drugs (ETDs) Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Endocrine Therapy Drugs (ETDs) Sales Value, 2019-2030

5.7.2 South America Endocrine Therapy Drugs (ETDs) Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Endocrine Therapy Drugs (ETDs) Sales Value, 2019-2030

5.8.2 Middle East & Africa Endocrine Therapy Drugs (ETDs) Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Endocrine Therapy Drugs (ETDs) Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Endocrine Therapy Drugs (ETDs) Sales Value

6.2.1 Key Countries/Regions Endocrine Therapy Drugs (ETDs) Sales Value, 2019-2030

6.2.2 Key Countries/Regions Endocrine Therapy Drugs (ETDs) Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Endocrine Therapy Drugs (ETDs) Sales Value, 2019-2030

6.3.2 United States Endocrine Therapy Drugs (ETDs) Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Endocrine Therapy Drugs (ETDs) Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Endocrine Therapy Drugs (ETDs) Sales Value, 2019-2030

6.4.2 Europe Endocrine Therapy Drugs (ETDs) Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Endocrine Therapy Drugs (ETDs) Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Endocrine Therapy Drugs (ETDs) Sales Value, 2019-2030

6.5.2 China Endocrine Therapy Drugs (ETDs) Sales Value by Type (%), 2023 VS 2030

6.5.3 China Endocrine Therapy Drugs (ETDs) Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Endocrine Therapy Drugs (ETDs) Sales Value, 2019-2030

6.6.2 Japan Endocrine Therapy Drugs (ETDs) Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Endocrine Therapy Drugs (ETDs) Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Endocrine Therapy Drugs (ETDs) Sales Value, 2019-2030

6.7.2 South Korea Endocrine Therapy Drugs (ETDs) Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Endocrine Therapy Drugs (ETDs) Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Endocrine Therapy Drugs (ETDs) Sales Value, 2019-2030

6.8.2 Southeast Asia Endocrine Therapy Drugs (ETDs) Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Endocrine Therapy Drugs (ETDs) Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Endocrine Therapy Drugs (ETDs) Sales Value, 2019-2030

6.9.2 India Endocrine Therapy Drugs (ETDs) Sales Value by Type (%), 2023 VS 2030

6.9.3 India Endocrine Therapy Drugs (ETDs) Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Novo Nordisk

7.1.1 Novo Nordisk Company Information

7.1.2 Novo Nordisk Introduction and Business Overview

7.1.3 Novo Nordisk Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Novo Nordisk Endocrine Therapy Drugs (ETDs) Product Offerings

7.1.5 Novo Nordisk Recent Development

7.2 AstraZeneca

7.2.1 AstraZeneca Company Information

7.2.2 AstraZeneca Introduction and Business Overview

7.2.3 AstraZeneca Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

7.2.4 AstraZeneca Endocrine Therapy Drugs (ETDs) Product Offerings

7.2.5 AstraZeneca Recent Development

7.3 Generex Biotechnology

7.3.1 Generex Biotechnology Company Information

7.3.2 Generex Biotechnology Introduction and Business Overview

7.3.3 Generex Biotechnology Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Generex Biotechnology Endocrine Therapy Drugs (ETDs) Product Offerings

7.3.5 Generex Biotechnology Recent Development

7.4 Sanofi

7.4.1 Sanofi Company Information

7.4.2 Sanofi Introduction and Business Overview

7.4.3 Sanofi Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Sanofi Endocrine Therapy Drugs (ETDs) Product Offerings

7.4.5 Sanofi Recent Development

7.5 MSD

7.5.1 MSD Company Information

7.5.2 MSD Introduction and Business Overview

7.5.3 MSD Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

7.5.4 MSD Endocrine Therapy Drugs (ETDs) Product Offerings

7.5.5 MSD Recent Development

7.6 Pfizer

7.6.1 Pfizer Company Information

7.6.2 Pfizer Introduction and Business Overview

7.6.3 Pfizer Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Pfizer Endocrine Therapy Drugs (ETDs) Product Offerings

7.6.5 Pfizer Recent Development

7.7 Huadong Medicine

7.7.1 Huadong Medicine Company Information

7.7.2 Huadong Medicine Introduction and Business Overview

7.7.3 Huadong Medicine Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Huadong Medicine Endocrine Therapy Drugs (ETDs) Product Offerings

7.7.5 Huadong Medicine Recent Development

7.8 Bayer

7.8.1 Bayer Company Information

7.8.2 Bayer Introduction and Business Overview

7.8.3 Bayer Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Bayer Endocrine Therapy Drugs (ETDs) Product Offerings

7.8.5 Bayer Recent Development

7.9 Tonghua Dongbao Pharmaceutical

7.9.1 Tonghua Dongbao Pharmaceutical Company Information

7.9.2 Tonghua Dongbao Pharmaceutical Introduction and Business Overview

7.9.3 Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Product Offerings

7.9.5 Tonghua Dongbao Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Endocrine Therapy Drugs (ETDs) Industrial Chain

8.2 Endocrine Therapy Drugs (ETDs) Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Endocrine Therapy Drugs (ETDs) Sales Model

8.5.2 Sales Channel

8.5.3 Endocrine Therapy Drugs (ETDs) Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

MSD

Huadong Medicine

Bayer

Tonghua Dongbao Pharmaceutical

Pfizer Inc

Generex Biotechnology

Astrazeneca plc

Novo Nordisk

Sanofi

List of Tables

Table 1. Endocrine Therapy Drugs (ETDs) Market Trends

Table 2. Endocrine Therapy Drugs (ETDs) Market Drivers & Opportunity

Table 3. Endocrine Therapy Drugs (ETDs) Market Challenges

Table 4. Endocrine Therapy Drugs (ETDs) Market Restraints

Table 5. Global Endocrine Therapy Drugs (ETDs) Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Endocrine Therapy Drugs (ETDs) Revenue Market Share by Company (2019-2024)

Table 7. Global Endocrine Therapy Drugs (ETDs) Sales Volume by Company (2019-2024) & (Kiloton)

Table 8. Global Endocrine Therapy Drugs (ETDs) Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Endocrine Therapy Drugs (ETDs) Price by Company (2019-2024) & (US$/Ton)

Table 10. Key Manufacturers Endocrine Therapy Drugs (ETDs) Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Endocrine Therapy Drugs (ETDs) Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Endocrine Therapy Drugs (ETDs)

Table 13. Global Endocrine Therapy Drugs (ETDs) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Therapy Drugs (ETDs) as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Endocrine Therapy Drugs (ETDs) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Endocrine Therapy Drugs (ETDs) Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Endocrine Therapy Drugs (ETDs) Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Endocrine Therapy Drugs (ETDs) Sales Volume by Type: 2019 VS 2023 VS 2030 (Kiloton)

Table 22. Global Endocrine Therapy Drugs (ETDs) Sales Volume by Type (2019-2024) & (Kiloton)

Table 23. Global Endocrine Therapy Drugs (ETDs) Sales Volume by Type (2025-2030) & (Kiloton)

Table 24. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Endocrine Therapy Drugs (ETDs) Price by Type (2019-2024) & (US$/Ton)

Table 27. Global Endocrine Therapy Drugs (ETDs) Price by Type (2025-2030) & (US$/Ton)

Table 28. Global Endocrine Therapy Drugs (ETDs) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Endocrine Therapy Drugs (ETDs) Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Endocrine Therapy Drugs (ETDs) Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Endocrine Therapy Drugs (ETDs) Sales Volume by Application: 2019 VS 2023 VS 2030 (Kiloton)

Table 34. Global Endocrine Therapy Drugs (ETDs) Sales Volume by Application (2019-2024) & (Kiloton)

Table 35. Global Endocrine Therapy Drugs (ETDs) Sales Volume by Application (2025-2030) & (Kiloton)

Table 36. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Endocrine Therapy Drugs (ETDs) Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Endocrine Therapy Drugs (ETDs) Price by Application (2019-2024) & (US$/Ton)

Table 39. Global Endocrine Therapy Drugs (ETDs) Price by Application (2025-2030) & (US$/Ton)

Table 40. Global Endocrine Therapy Drugs (ETDs) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Endocrine Therapy Drugs (ETDs) Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Endocrine Therapy Drugs (ETDs) Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Endocrine Therapy Drugs (ETDs) Sales Value by Region (2019-2024) & (%)

Table 44. Global Endocrine Therapy Drugs (ETDs) Sales Value by Region (2025-2030) & (%)

Table 45. Global Endocrine Therapy Drugs (ETDs) Sales Volume by Region (Kiloton): 2019 VS 2023 VS 2030

Table 46. Global Endocrine Therapy Drugs (ETDs) Sales Volume by Region (2019-2024) & (Kiloton)

Table 47. Global Endocrine Therapy Drugs (ETDs) Sales Volume by Region (2025-2030) & (Kiloton)

Table 48. Global Endocrine Therapy Drugs (ETDs) Sales Volume by Region (2019-2024) & (%)

Table 49. Global Endocrine Therapy Drugs (ETDs) Sales Volume by Region (2025-2030) & (%)

Table 50. Global Endocrine Therapy Drugs (ETDs) Average Price by Region (2019-2024) & (US$/Ton)

Table 51. Global Endocrine Therapy Drugs (ETDs) Average Price by Region (2025-2030) & (US$/Ton)

Table 52. Key Countries/Regions Endocrine Therapy Drugs (ETDs) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Endocrine Therapy Drugs (ETDs) Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Endocrine Therapy Drugs (ETDs) Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Endocrine Therapy Drugs (ETDs) Sales Volume, (2019-2024) & (Kiloton)

Table 56. Key Countries/Regions Endocrine Therapy Drugs (ETDs) Sales Volume, (2025-2030) & (Kiloton)

Table 57. Novo Nordisk Company Information

Table 58. Novo Nordisk Introduction and Business Overview

Table 59. Novo Nordisk Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 60. Novo Nordisk Endocrine Therapy Drugs (ETDs) Product Offerings

Table 61. Novo Nordisk Recent Development

Table 62. AstraZeneca Company Information

Table 63. AstraZeneca Introduction and Business Overview

Table 64. AstraZeneca Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 65. AstraZeneca Endocrine Therapy Drugs (ETDs) Product Offerings

Table 66. AstraZeneca Recent Development

Table 67. Generex Biotechnology Company Information

Table 68. Generex Biotechnology Introduction and Business Overview

Table 69. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 70. Generex Biotechnology Endocrine Therapy Drugs (ETDs) Product Offerings

Table 71. Generex Biotechnology Recent Development

Table 72. Sanofi Company Information

Table 73. Sanofi Introduction and Business Overview

Table 74. Sanofi Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 75. Sanofi Endocrine Therapy Drugs (ETDs) Product Offerings

Table 76. Sanofi Recent Development

Table 77. MSD Company Information

Table 78. MSD Introduction and Business Overview

Table 79. MSD Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 80. MSD Endocrine Therapy Drugs (ETDs) Product Offerings

Table 81. MSD Recent Development

Table 82. Pfizer Company Information

Table 83. Pfizer Introduction and Business Overview

Table 84. Pfizer Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 85. Pfizer Endocrine Therapy Drugs (ETDs) Product Offerings

Table 86. Pfizer Recent Development

Table 87. Huadong Medicine Company Information

Table 88. Huadong Medicine Introduction and Business Overview

Table 89. Huadong Medicine Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 90. Huadong Medicine Endocrine Therapy Drugs (ETDs) Product Offerings

Table 91. Huadong Medicine Recent Development

Table 92. Bayer Company Information

Table 93. Bayer Introduction and Business Overview

Table 94. Bayer Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 95. Bayer Endocrine Therapy Drugs (ETDs) Product Offerings

Table 96. Bayer Recent Development

Table 97. Tonghua Dongbao Pharmaceutical Company Information

Table 98. Tonghua Dongbao Pharmaceutical Introduction and Business Overview

Table 99. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 100. Tonghua Dongbao Pharmaceutical Endocrine Therapy Drugs (ETDs) Product Offerings

Table 101. Tonghua Dongbao Pharmaceutical Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Endocrine Therapy Drugs (ETDs) Downstream Customers

Table 105. Endocrine Therapy Drugs (ETDs) Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Endocrine Therapy Drugs (ETDs) Product Picture

Figure 2. Global Endocrine Therapy Drugs (ETDs) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Endocrine Therapy Drugs (ETDs) Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Endocrine Therapy Drugs (ETDs) Sales Volume (2019-2030) & (Kiloton)

Figure 5. Global Endocrine Therapy Drugs (ETDs) Sales Price (2019-2030) & (US$/Ton)

Figure 6. Endocrine Therapy Drugs (ETDs) Report Years Considered

Figure 7. Global Endocrine Therapy Drugs (ETDs) Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Endocrine Therapy Drugs (ETDs) Players Sales Volume Ranking (2023) & (Kiloton)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Endocrine Therapy Drugs (ETDs) Revenue in 2023

Figure 10. Endocrine Therapy Drugs (ETDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Antidiabetic Drugs Picture

Figure 12. Anti-osteoporosis Drugs Picture

Figure 13. Contraceptive Picture

Figure 14. Other Picture

Figure 15. Global Endocrine Therapy Drugs (ETDs) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Endocrine Therapy Drugs (ETDs) Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Endocrine Therapy Drugs (ETDs) Sales Volume by Type (2019 VS 2023 VS 2030) & (Kiloton)

Figure 18. Global Endocrine Therapy Drugs (ETDs) Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Endocrine Therapy Drugs (ETDs) Price by Type (2019-2030) & (US$/Ton)

Figure 20. Product Picture of Diabetes Treatment

Figure 21. Product Picture of Osteoporosis Treatment

Figure 22. Product Picture of Contraception

Figure 23. Product Picture of Other

Figure 24. Global Endocrine Therapy Drugs (ETDs) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Endocrine Therapy Drugs (ETDs) Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Endocrine Therapy Drugs (ETDs) Sales Volume by Application (2019 VS 2023 VS 2030) & (Kiloton)

Figure 27. Global Endocrine Therapy Drugs (ETDs) Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Endocrine Therapy Drugs (ETDs) Price by Application (2019-2030) & (US$/Ton)

Figure 29. North America Endocrine Therapy Drugs (ETDs) Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Endocrine Therapy Drugs (ETDs) Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Endocrine Therapy Drugs (ETDs) Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Endocrine Therapy Drugs (ETDs) Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Endocrine Therapy Drugs (ETDs) Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Endocrine Therapy Drugs (ETDs) Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Endocrine Therapy Drugs (ETDs) Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Endocrine Therapy Drugs (ETDs) Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Endocrine Therapy Drugs (ETDs) Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Endocrine Therapy Drugs (ETDs) Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Endocrine Therapy Drugs (ETDs) Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Endocrine Therapy Drugs (ETDs) Sales Volume (%), (2019-2030)

Figure 41. United States Endocrine Therapy Drugs (ETDs) Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Endocrine Therapy Drugs (ETDs) Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Endocrine Therapy Drugs (ETDs) Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Endocrine Therapy Drugs (ETDs) Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Endocrine Therapy Drugs (ETDs) Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Endocrine Therapy Drugs (ETDs) Sales Value by Application (%), 2023 VS 2030

Figure 47. China Endocrine Therapy Drugs (ETDs) Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Endocrine Therapy Drugs (ETDs) Sales Value by Type (%), 2023 VS 2030

Figure 49. China Endocrine Therapy Drugs (ETDs) Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Endocrine Therapy Drugs (ETDs) Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Endocrine Therapy Drugs (ETDs) Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Endocrine Therapy Drugs (ETDs) Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Endocrine Therapy Drugs (ETDs) Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Endocrine Therapy Drugs (ETDs) Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Endocrine Therapy Drugs (ETDs) Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Endocrine Therapy Drugs (ETDs) Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Endocrine Therapy Drugs (ETDs) Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Endocrine Therapy Drugs (ETDs) Sales Value by Application (%), 2023 VS 2030

Figure 59. India Endocrine Therapy Drugs (ETDs) Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Endocrine Therapy Drugs (ETDs) Sales Value by Type (%), 2023 VS 2030

Figure 61. India Endocrine Therapy Drugs (ETDs) Sales Value by Application (%), 2023 VS 2030

Figure 62. Endocrine Therapy Drugs (ETDs) Industrial Chain

Figure 63. Endocrine Therapy Drugs (ETDs) Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions